Chronic intestinal disorders (CID) are characterized by persistent, or recurrent gastroin-testinal (GI) signs present for at least three weeks. In human medicine, inflammatory bowel disease (IBD) is a group of chronic GI diseases and includes Crohn’s disease (CD) and ulcerative colitis (UC). On the other hand, the general term chronic enteropathies (CE) is preferred in veterinary medicine. Different therapeutic approaches to these diseases are used in both humans and pets. This review is focused on the use of traditional therapies and nutraceuticals with specific antioxidant properties, for the treatment of CID in humans and animal patients. There is strong evidence of the antioxidant properties of the nutraceuticals included in this review, but few studies report their use for treating CID in humans and none in animals. Despite this fact, the majority of the nutraceuticals described in the present article could be considered as promising alternatives for the regular treatment of CID in human and veterinary medicine.

Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives

Meineri G.
First
;
Martello E.
;
Radice E.;Saettone V.;Atuahene D.;Armandi A.;Testa G.;Ribaldone D. G.
Last
2022-01-01

Abstract

Chronic intestinal disorders (CID) are characterized by persistent, or recurrent gastroin-testinal (GI) signs present for at least three weeks. In human medicine, inflammatory bowel disease (IBD) is a group of chronic GI diseases and includes Crohn’s disease (CD) and ulcerative colitis (UC). On the other hand, the general term chronic enteropathies (CE) is preferred in veterinary medicine. Different therapeutic approaches to these diseases are used in both humans and pets. This review is focused on the use of traditional therapies and nutraceuticals with specific antioxidant properties, for the treatment of CID in humans and animal patients. There is strong evidence of the antioxidant properties of the nutraceuticals included in this review, but few studies report their use for treating CID in humans and none in animals. Despite this fact, the majority of the nutraceuticals described in the present article could be considered as promising alternatives for the regular treatment of CID in human and veterinary medicine.
12
7
812
832
Chronic enteropathies; Inflammatory bowel disease; Nutraceuticals; Phytocomplex; Trace elements; Ulcerative colitis; Vitamins
Meineri G.; Martello E.; Radice E.; Bruni N.; Saettone V.; Atuahene D.; Armandi A.; Testa G.; Ribaldone D.G.
File in questo prodotto:
File Dimensione Formato  
Chronic Intestinal Disorders in Humans and Pets.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 695.8 kB
Formato Adobe PDF
695.8 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1853663
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact